ArTS Archivio della ricerca di Trieste

ZORZET, SONIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.229
EU - Europa 4.865
AS - Asia 992
AF - Africa 28
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 10
Totale 13.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.204
PL - Polonia 1.348
UA - Ucraina 757
SE - Svezia 704
IT - Italia 596
CN - Cina 410
DE - Germania 404
FI - Finlandia 218
HK - Hong Kong 215
GB - Regno Unito 179
RU - Federazione Russa 170
TR - Turchia 149
FR - Francia 117
IE - Irlanda 116
BG - Bulgaria 115
TW - Taiwan 56
SG - Singapore 45
BE - Belgio 42
VN - Vietnam 41
CH - Svizzera 20
CA - Canada 19
SN - Senegal 19
NL - Olanda 18
IN - India 16
JP - Giappone 16
KR - Corea 11
EU - Europa 10
IR - Iran 10
AT - Austria 9
CZ - Repubblica Ceca 8
AU - Australia 7
MD - Moldavia 7
PT - Portogallo 6
RO - Romania 6
BR - Brasile 5
CL - Cile 5
ES - Italia 5
MA - Marocco 5
MX - Messico 4
MY - Malesia 4
EE - Estonia 3
GR - Grecia 3
HR - Croazia 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ID - Indonesia 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
PK - Pakistan 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AN - Antille olandesi 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 13.151
Salva come PNG Salva come JPEG
Città #
Warsaw 1.341
Woodbridge 945
Ann Arbor 887
Fairfield 793
Jacksonville 608
Houston 604
Chandler 580
Wilmington 465
Ashburn 415
Seattle 341
Cambridge 253
Princeton 221
Hong Kong 212
Trieste 171
Beijing 142
Izmir 128
Sofia 115
Dublin 113
Dearborn 84
Boardman 70
San Diego 58
Taipei 51
Milan 47
Brussels 36
Falls Church 33
Singapore 29
Redwood City 28
Saint Petersburg 27
Chicago 26
Düsseldorf 25
Nanjing 23
Hefei 22
Verona 22
Dong Ket 21
Helsinki 20
Mestre 20
Norwalk 20
Dakar 19
Munich 19
Kocaeli 18
Bremen 17
Kunming 17
Kyiv 17
Moscow 17
Phoenix 17
Shanghai 16
Buffalo 15
Bern 13
Des Moines 13
Jinan 13
Guangzhou 12
Washington 11
Columbus 10
Buon Ma Thuot 9
New York 9
Padova 9
Seoul 9
Dagenham 8
Fuzhou 8
Southend 8
Andover 7
Nanchang 7
Toronto 7
Cascina 6
Fremont 6
Grafing 6
Hangzhou 6
Ho Chi Minh City 6
Kazan 6
Sacile 6
Udine 6
Amsterdam 5
Auburn Hills 5
Brno 5
Frankfurt am Main 5
Langenfeld 5
London 5
Los Angeles 5
Modena 5
Palermo 5
Torre Del Greco 5
Vicenza 5
Vienna 5
Wuhan 5
Baotou 4
Chongqing 4
Dongguan 4
Kaohsiung City 4
Monfalcone 4
Paris 4
Sarapul 4
Shenyang 4
Sint-Genesius-Rode 4
Sydney 4
Torino 4
Trivandrum 4
Zhengzhou 4
Boydton 3
Chaoyang 3
Chengdu 3
Totale 9.495
Salva come PNG Salva come JPEG
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 635
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 398
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 388
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 342
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 333
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies 324
Photosensitizing Activity of Pegylated Pheophorbide a 309
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 287
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 224
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 221
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 190
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 180
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 175
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results 160
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 158
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 156
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 155
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 153
Complessi trans di rutenio come agenti antineoplastici 148
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 143
Stress and chemotherapy. Combined effects on tumor progression and immunity in animal models 139
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. 138
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 136
Inhibition of B16 Melanoma Metastases with the Ruthenium Complex Imidazolium trans-Imidazoledimethylsulfoxide-tetrachlororuthenate and Down-Regulation of Tumor Cell Invasion. 134
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 134
null 127
Tumour metastatic potential after treatment with selective antimetastatic drugs 127
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 126
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 125
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. 124
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 124
Metal complexes of platinum group: the promising antitumor features of cis-dichlorotetrakis(dimethylsulfoxide)Ru(II) (cis- RuCl2(DMSO)4) and related complexes 123
Cis- and trans-dihalotetrakis(dimethylsulfoxide)Ruthenium(II) Complexes (RuX2(Me2SO)4; X = Cl, Br): Synthesis, Structure and Antitumor Activity 122
Complessi di Rutenio con elevata attività antitumorale 122
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 118
null 117
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells. 116
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 116
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 114
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 113
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 113
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 111
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 110
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice 108
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 106
Ruthenium dimeric compounds suitable as antimetastatic and antineoplastic agents 105
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But 103
null 103
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: an in vitro study 103
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 103
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 101
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 101
Ruthenium complexes with anti-neoplastic agent 101
Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins 101
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. 100
Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors 100
Role of host responses in the drug treatment of metastasis 100
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 100
Ruthenium complexes with high antitumoral and antimetastatic activities 99
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 99
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice. 99
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 97
PHOTOSENSITIZING ACTIVITY OF PEGYLATED PHEOPHORBIDE a 95
Nitric oxide-mediated activity in anti-cancer photodynamic therapy 94
Synthesis and Chemical-Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl [1,2,4]triazolo [1,5-a]pyrimidine) 92
Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 92
Activity and inhibition by cytotoxic antimetastatic drugs of cathepsin B-like cysteine proteinases in transplantable leukemias in mice 91
Is effectiveness of cancer chemotherapy influenced by stress? 91
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity 90
Melatonin administration in tumor-bearing mice (intact and pinealectomized)in relation to stress, zinc, thymulin and IL-2. 90
Coordination metal complexes of Rh(I), Ir(I) and Ru(II): recent advances on antimetastatic activity on solid mouse tumors 90
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 89
Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines 89
Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report 86
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic drugs 86
The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis 86
Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. 85
Conjugated PDT drug. Phptosensitizing activity and tissue distribution of PEGylated pheophorbide a 85
DTIC e i suoi derivati: farmaci citotossici o antimetastatici? 85
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 84
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs. 83
Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing Lewis lung carcinoma. 82
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells. 82
Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung arcinoma 81
Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study 81
Antineoplastic Activity of planar Rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia 80
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 78
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 77
Synthesis of *-Alkylmethylen-2-oxo-chromanes with anticoagulant activity and *-Alkylmethylen-*-lactones from 3-Diethylphosphono-3,4-dihydrocoumarins, 3-Diethylphosphonolactones and Aldehydes. Part 2' 77
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 77
Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. 76
Effects of dimethyltriazenes combined with surgery and non-specific immunotherapy in mice bearin Lewis lung carcinoma lines 75
Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis lung carcinoma treated with proteinase inhibitors 74
Synthesis and structure-activity relationships of α-alkylmethylen-2-oxo-chromanes with anticoagulant activity 72
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for thePhotodynamic Therapy 69
Infiltration of liver and brain by tumor cells in leukemik mice: prevention by dimethyltriazenes and cyclophosphamide. 68
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A 68
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 65
Lack of in vitro cytotoxicity, associated to increased G2-M cell fraction and inhibition of matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes 59
Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice 58
Totale 12.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019733 0 0 0 0 0 0 0 0 0 0 494 239
2019/20202.719 144 126 133 453 191 358 284 307 250 184 215 74
2020/20211.939 184 86 165 232 133 241 155 178 127 198 80 160
2021/20221.594 67 112 90 181 25 124 57 107 215 150 82 384
2022/20231.818 181 233 142 237 187 313 25 165 214 24 69 28
2023/2024909 72 61 83 60 112 76 135 203 15 37 55 0
Totale 13.573